Anti-uPA Receptor/U-PAR antibody [EPR20191]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal uPA Receptor/U-PAR antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 8 publications.
View Alternative Names
CD87, MO3, UPAR, PLAUR, Urokinase plasminogen activator surface receptor, U-PAR, uPAR, Monocyte activation antigen Mo3
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
Immunohistochemical analysis of paraffin-embedded human ovarian cancer tissue labeling uPA Receptor/U-PAR with ab218106 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Membranous staining on dissociative cancer cells in blood vessel of human ovarian cancer is observed [PMID : 25120753].
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
Immunohistochemical analysis of paraffin-embedded human lung cancer tissue labeling uPA Receptor/U-PAR with ab218106 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Cytoplasmic staining on the stromal cells of human lung cancer is observed [PMID : 25575713].
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
Immunohistochemical analysis of paraffin-embedded human ovarian cancer tissue labeling uPA Receptor/U-PAR with ab218106 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Membranous staining on the macrophages of human ovarian cancer is observed [PMID : 25575713].
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
Immunohistochemical analysis of paraffin-embedded human artery tissue labeling uPA Receptor/U-PAR with ab218106 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Positive staining on the neutrophils in human artery is observed [PMID : 25575713].
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-uPA Receptor/U-PAR antibody [EPR20191] (AB218106)
Blocking/Dilution buffer : 5% NFDM/TBST.
PMA-stimulated U937 cells express uPA Receptor/U-PAR in the range of 35kDa-60kDa. Non-stimulated U937 cells are negative. The deglycosylated form of the protein is at 35 kDa and the highly glycosylated protein is at 60kDa (PMID : 24999729).
All lanes:
Western blot - Anti-uPA Receptor/U-PAR antibody [EPR20191] (ab218106) at 1/1000 dilution
Lane 1:
Untreated U937 (Human histiocytic lymphoma cell line) whole cell lysate at 10 µg
Lane 2:
U937 whole cell lysate treated with 200nM PMA (Phorbol-12-myristate-13-acetate) for 72 hours at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 37 kDa
Observed band size: 35-65 kDa
false
Exposure time: 15s
Related conjugates and formulations (1)
-
Anti-uPA Receptor/U-PAR antibody [EPR20191] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Clinical and molecular hepatology 31:935-959 PubMed39924997
2025
Applications
Unspecified application
Species
Unspecified reactive species
ACS omega 8:33392-33402 PubMed37744847
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell stress & chaperones 28:253-263 PubMed37052764
2023
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabn3774 PubMed35613265
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:862723 PubMed35574375
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:666446 PubMed33968773
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cancer research and clinical oncology 146:2189-2203 PubMed32488496
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research 38:214 PubMed31118109
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com